Delivery Order SPE2DB22D3009-SPE2DB24FAY99

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $5,234.38 and a completion date of June 10, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $1,153.40 and an ultimate completion date of April 23, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen Drug Corp...
This federal contract award, valued at $10,263.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the purchase of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with a completion date of June 20, 2024. Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distribution companies in the world, holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $5,404.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a completion date of June 26, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a...
This federal contract award, valued at $11,235.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical product, and is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $5,702.72 with a completion date of July 25, 2024. It is a Firm Fixed Price contract for the supply of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $25,106.82, is for the delivery of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. It is a firm fixed-price delivery order with a completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,872.64, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is a Delivery Order for the supply of 4564543637 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of May 9, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a $2,052.90 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 25 mcg/0.5 mL TYPHIM VI syringes by May 1, 2024. This award is under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...
This contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The fixed-price delivery order contract has a ceiling value of $20,371.16 and a completion date of August 28, 2024. Amerisourcebergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to provide essential medical commodities, including...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FAY99
    Delivery Order

This federal contract award, with a ceiling value of $1,368.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with a period of performance through June 21, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was made on a full and open competition basis without any set-aside designation.

Generated 9/19/24, 9:28 AM